BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2017 2:36:58 AM | Browse: 1188 | Download: 1643
 |
Received |
|
2017-07-11 20:58 |
|
Peer-Review Started |
|
2017-07-12 01:39 |
|
To Make the First Decision |
|
2017-08-10 00:15 |
|
Return for Revision |
|
2017-08-10 06:51 |
|
Revised |
|
2017-09-06 09:14 |
|
Second Decision |
|
2017-09-08 02:07 |
|
Accepted by Journal Editor-in-Chief |
|
2017-09-08 21:32 |
|
Accepted by Executive Editor-in-Chief |
|
2017-09-13 03:02 |
|
Articles in Press |
|
2017-09-13 03:02 |
|
Publication Fee Transferred |
|
2017-09-22 05:26 |
|
Edit the Manuscript by Language Editor |
|
2017-11-08 23:39 |
|
Typeset the Manuscript |
|
2017-11-17 02:33 |
|
Publish the Manuscript Online |
|
2017-11-27 02:36 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Dramatic response of hepatitis C patients chronically infected with Hepatitis C virus genotype 3 to Sofosbuvir based therapies in Punjab, Pakistan: A prospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sajjad Iqbal, Muhammad Haroon Yousuf and Muhammad Iftikhar Yousaf |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sajjad Iqbal, PhD, Doctor, Doctor, Pathology, Shalamar Hospital, Shalimar Link road Mughal Pura, Lahore 54840, Punjab, Pakistan. sajjad.iqbal@sihs.org.pk |
| Key Words |
Sofosbuvir; Sustained virological response; Pakistan |
| Core Tip |
Previously, Hepatitis C was treated with Interferon based therapies. Intolerable side effects, prolonged treatment duration, and unsatisfactory response rates were the major droughts of those therapies. The introduction of Sofosbuvir (SOF) that was claimed highly responding oral drug for Hapatitis C patients with its minimal side effects in different trials, it was important to see its efficacy in our population. We found outstanding response rate of SOF in HCV genotype 3 infected patients. These findings shows that with proper and timely use of SOF based therapy may help to get rid of Hepatitis C from our population. |
| Publish Date |
2017-11-27 02:36 |
| Citation |
Iqbal S, Yousuf MH, Yousaf MI. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study. World J Gastroenterol 2017; 23(44): 7899-7905 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/ i44/7899.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i44.7899 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
